Hemoglobin (Hb) E (βGlu26Lys) remains an enigma in terms of its contributions to red blood cell (RBC) pathophysiological mechanisms: e.g., EE individuals exhibit a mild, chronic anemia while HbE/β thalassemia individuals show a range of clinical manifestations, including high morbidity and death, often resulting from cardiac dysfunction. The purpose of the present study is to determine and evaluate structural and functional consequences of the HbE mutation that might account for the pathophysiology. Functional studies indicate minimal allosteric consequence to both oxygen and carbon monoxide binding properties of the ferrous derivatives of HbE. In contrast, redox sensitive reactions are clearly impacted as seen in (1) the ~ 2.5 times decrease in the rate at which HbE catalyzes nitrite reduction to nitric oxide (NO) relative to HbA and (2) the accelerated rate of reduction of aquomet HbE by L-cysteine (LCys). Sol-gel encapsulation studies imply a shift towards a higher redox potential for both the T and R HbE structures which can explain the origin of the reduced nitrite reductase activity of deoxy HbE and the accelerated rate of reduction of aquomet HbE by cysteine. Deoxy and CO HbE crystal structures (derived from crystals grown at or near physiological pH) show loss of hydrogen bonds in the microenvironment of β26Lys and no significant tertiary conformational perturbations at the allosteric transition sites in the R and T states. Together these data suggest a model in which the HbE mutation, as a consequence of a relative change in redox properties, decreases the overall rate of Hb mediated production of bioactive NO.
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Hemoglobinopathies are inherited disorders of hemoglobin that arise from globin gene mutations, with over 90% due to point mutations. More than 1451 hemoglobinopathies and thalassemias have been identified and listed in the HbVar Database (http://globin.cse.psu.edu/hbvar/, September 1, 2010) (1) . Many of these mutations, give rise to diverse molecular diseases, with unique pathogenesis (2) . While many hemoglobinopathies arise from altered oxygen carrying properties and/or tetramer instability, there are also several hemoglobin variants that do not fall into any of the obvious standard categories. In such cases, the molecular basis for the pathophysiology is at best ambiguous.
The most common worldwide Hb mutation is HbE (βGlu26Lys). This β E -globin allele imparts a selective advantage for resistance to malaria as does HbS and HbC (3, 4) . Renewed interest in the mechanisms of HbE diseases and HbE/β-thalassemia originated with the wave of migration from Southeast Asia to Europe and North America (5) . HbE hemoglobinopathies, including HbE/β-thalassemia, manifest a heterogenous clinical spectrum, from asymptomatic to severe. HbEE homozygotes are asymptomatic with a very mild chronic anemia and microcytosis. This clinical presentation has been attributed to the minimally reduced expression of β E messenger RNA (6,7) that originates from the generation of an alternative splice site created in the reading frame by the mutation [a single nucleotide substitution (GAG→AAG)]. The consequence of a reduction in β E -globin expression would lead to a small percentage of free α-chains, known to be highly unstable.
In contrast to the mild clinical manifestations both of HbEE homozygotes, HbAE traits and of β-thalassemia trait individuals (e.g., HbA/β-thalassemia), the heterozygous condition of HbE/β-thalassemia is probably the most common severe hemoglobinopathy world-wide, and presents a diverse clinical spectrum with variations in anemia, growth, development, hepatosplenomegaly, and transfusion requirements (8) (9) (10) (11) . At birth, infants are asymptomatic which is attributed to high HbF levels (12) . Secondary morbid clinical manifestations arise, in part, as a result of ineffective erythropoiesis and iron overload that resemble those of untreated β-thalassemia major (13) . The molecular mechanisms giving rise to the variable pathophysiology of HbE/β 0 -thalassemia are still largely undetermined (14) . Contributions to the phenotype also include (a) the co-existence of α-thalassemia (which diminishes the α/β chain imbalance) (15) ; (b) the presence of the C → T mutation in position -158 in from γ G resulting in an increased synthesis of HbF that seems to ameliorate the disease (7, 16) ; and (c) genetic modifiers that alter the HbE/β 0 -thalassemia phenotype (17, 18) .
A major unanswered question is, how does the HbE mutation contribute to the β 0 -thalassemia dependent spectrum of pathophysiologies in HbE disease? Oxygen binding properties of HbE appear to be similar to that of HbA: the HbE tetramer is reported to exhibit normal oxygen binding in the presence of phosphates and at physiological ionic strength (19) , but an increase in oxygen affinity under conditions of low salt concentration (20) . Biochemical studies in vitro established a decreased stability of HbE attributed to the positively charged substitution at the site of mutation located near the α 1 β 1 interface (21) (22) (23) (24) that has yet to be linked to in vivo RBC alterations and pathophysiology (13) . It has been proposed that this instability may only play a role during febrile episodes (25) . Regardless, to date, there is no known molecular mechanism or functional consequence of the HbE mutation that accounts for the pathophysiology of HbE diseases.
In the present study, structural and functional properties of HbE are compared to those of HbA. High resolution X-ray crystallography and solution phase circular dichroism are used to examine the structural properties of HbE. Oxygen affinity measurements for solution phase samples and CO recombination kinetics for T and R state derivatives encapsulated in sol-gel matrices are used to compare the ligand binding reactivity of the ferrous derivatives of HbE and HbA. The nitrite reductase (NR) activity of HbE and HbA is also compared.
The NR reaction is of potential significance in that it yields nitric oxide (NO), a molecule vital for the integrity of the endothelium and cardiac function. Recently, normal hemoglobin function has been broadened beyond that of an oxygen carrier to include a role as a physiologically significant source of bioactive nitric oxide (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) . One of several proposed NO generating reactions of hemoglobin is the nitrite reductase reaction in which the five coordinate ferrous heme reacts with the nitrite ion yielding an NO molecule and a met (ferric) heme. The reaction rate has been shown to be quaternary structure dependent (36, 40, 41) with evidence supporting the idea that the quaternary state sensitivity arises from the higher redox potential of the T quaternary state versus the R quaternary state (42) . The role of redox potential in this reaction has been questioned (43) . The present work also aims to address this issue with respect to HbA and HbE.
In the present work, HbA and HbE are compared with respect to nitrite reductase reactivity at pH 7.0 and 7.4. The higher pH is used to enhance the contribution of R state intermediates in the reaction. The pH 7.4 measurements also include the effect of a potent allosteric effector L35 (2-[4-(3,5-dichlorophenylureido) phenoxy] -2-methylpropionic acid) (44) which is used to stabilize T state species and thus provide a means of clearly separating T and R state NR kinetics at pH 7.4
The reduction of aquomet heme to ferrous five coordinate heme by L-cysteine (L-Cys) (45) is protein dependent (45, 46) and sensitive to the heme redox potential (47) . L-Cysteine mediated reduction of aquomet Hb to deoxy Hb both in solution and in a sol-gel matrix is used in this study as a means of evaluating differences in the redox activity of the two proteins for both the T and R state. This comparison is used to help evaluate whether changes in the NR activity of HbE might arise from an alteration in the redox properties of the heme.
Overall, this study reveals, for both the T and R states of HbE and HbA, substantial differences in the rates of the nitrite reductase reaction and the L-Cys mediated reduction of met Hb. These findings are consistent with the HbE mutation causing an increase in the redox potential of both the T and R states for this Hb. This in vitro finding raises the interesting possibility that a decreased overall rate of HbE mediated production of bioactive NO is a factor in exacerbating the β-thalassemia-induced inflammation. A model is presented regarding the role of HbE as a contributing factor to the HbE/β-thalassemia clinical picture.
Experimental Procedures
Hemoglobin purification. Human HbE was purified from red blood cells (RBC) obtained from transgenic mice expressing human HbE as described earlier in (48) . Human HbE purified from transgenic mouse RBC contains solely HbE, lacking contamination from HbA 2 as occurs in human red blood cells. Since HbA 2 and HbE have a very similar isoelectric point, separation is not feasible. The structural correctness of human HbE expressed by transgenic mice is verified by a variety of techniques, HPLC, mass spectrometry, isoelectric focusing, absorption spectrophotometry (48) .
The hemoglobins were separated and purified from the mouse hemolysates using a DE-52 anion exchanger column equilibrated in a 0.2M glycine buffer adjusted to pH 7.8 with saturated KOH (Developer A). A gradient was created with the starting buffer (Developer A) and [Developer A + 0.005N NaCl (0.293g/1000mL)]. The eluant was then concentrated and dialyzed for further purification on a CM-52 cation exchanger (10mM potassium phosphate, pH 6.5). After HbE separation and purification, the sample was concentrated and brought to equilibrium in the desired buffer by passage through a Sephadex G-25 column. The sample was then concentrated and further dialyzed against the experimental buffer. Purified human HbE was verified by mass spectrometry, HPLC, and IEF as described in (48) .
Human HbA was purified as described earlier (41, 49) . Crystallography: Carbonmonoxy (CO) HbE crystal growth. Solutions of oxy HbE were converted to COHbE by exposure to CO gas without bubbling. Complete conversion, and the absence of met HbE, was confirmed by the visible absorption spectra at 500-700 nm. The CO liganded form was chosen for study, rather than the oxy form, because: (i) hemoglobin is more stable in the CO form, being less prone to oxidation (50, 51) , and (ii) only minor local differences exist between the crystal structures of R-state COHbA and oxyHbA (51) .
Crystals were grown at ambient temperature by a modification of the (52) batch method (53) (54) . The largest and best crystals grew in either 1.65M potassium phosphate, pH 7.35, 2.5% purified HbE or 1.60M potassium phosphate, pH 7.35, 3.0% purified HbE and diffracted to 1.8Å The Hb stock solution was gently exposed to CO gas without bubbling, added to the CO precipitating phosphate buffer and then exposed to CO again. Large crystals (~1 mm) grew by the next day. The COHbE crystal used for diffraction data collection was formed in 1.6M potassium phosphate ("high salt") at pH 7.35. Diffraction from these crystals is consistent with the tetragonal space group P4 1 2 1 2 with unit cell dimensions a=b= 53.5 Å, c= 192.0 Å, α= β= γ= 90° and a half of the HbE tetramer in the asymmetric unit.
Low ionic strength crystallization conditions were derived from the Crystal Screen HTP (Hampton Research, CA). In this case, 1 μL of 25 mg/mL HbE (βGlu26Lys) was mixed in a sitting drop with 1 μL of reservoir solution containing 0.1 M Na-HEPES, pH 7.5, 10% iso-propanol, 20% polyethylene glycol 4000, and samples were equilibrated against reservoir solution at 21 o C for 3 weeks. Before sealing trays were incubated inside the CO-filled box to convert HbE into the carbomonoxy form. Diffraction from these crystals is consistent with the space group P2 1 X-ray data collection and refinement. Before data collection, protein crystals of COHbE were soaked for a few minutes in CO-saturated mother liquor containing 20% glycerol as cryoprotectant. Then crystals were flash-frozen in liquid nitrogen, and diffraction data were collected with CuKα radiation (λ= 1.54 Å) using in-house RaxisIV++ detector coupled with RU300 rotating anode generator (Rigaku, Woodlands, USA). Crystals of deoxy-HbE were transferred (inside N 2 incubator) to the mother liquor containing 20% glycerol as the cryoprotectant and then flash-cooled in liquid nitrogen. Diffraction data were collected at the X3A beamline (Brookaven National Laboratory, Upton) using 0.979 Å radiation and a MarCCD 165 mm detector (MarResearch, Hamburg). Intensities were integrated using the program HKL2000 (56) and reduced to amplitudes using the program TRUNCATE (57) see Table 1 for statistics. The structures were determined by molecular replacement with PHASER. Model building and refinement were performed with the programs REFMAC and COOT (58, 59 ). The quality of the final structure was verified with composite omit maps, and the stereochemistry was checked with the programs (60)WHATCHECK and PROCHEK (61). The LSQKAB and SSM algorithms (56) were used for structural superimpositions (57,62). The refinement statistics and unit cell parameters are shown in Table 1 . Protein Data Bank Entries. The COHbE structures were deposited with the Protein Data Bank under entry codes 1YVQ (low salt conditions) and 1YVT (high salt conditions), and the deoxy HbE structure was deposited under entry code 3DUT. Solution preparation: Samples for solution studies (0.22 mM heme) were prepared as deoxy in an oxygen free glove box by exhaustive purging with Ar, and adding a modest excess dithionite (>1:1 dithionite:heme ) as necessary. Samples used to prepare sol-gels were prepared similarly. The thin film nature of the sol-gel preparation requires a higher concentration of Hb than for the solution phase studies resulting in a higher OD for the solgel samples compared to the solution phase studies. The visible to near IR optical absorption spectra of samples in Bis-Tris buffer, pH 7.0 and 7.4, were scanned to establish the ligation and redox status of the heme. COHb samples were prepared by exposing the deoxy samples to buffer saturated CO gas, until the absorption spectrum revealed complete conversion to COHb derivative. Aquomet samples were prepared by oxidizing Hb using K 3 Fe(CN) 6 , which was subsequently removed using a spin column prepared from G10 Sephadex using the same buffer. Sol-Gel preparation. Hemoglobin was encapsulated in a thin film of silane derived solgel according to published procedures described in (41) . Basically, tetramethylorthosilicate (TMOS), hydrolyzed using 2 mM HCl, is mixed in a 1:1 ratio with protein solubilized in 0.05 M Bis-Tris OAc buffer, pH 7.0. The resulting solution is spun in a 1 cm wide NMR-tube until gelation occurs creating a thin film of an Hb-containing gel on the bottom fourth of the tube. A final concentration of 0.45 mM in heme for the encapsulated Hb is required to produce a high optical quality thin film.
After the sol-gel is allowed to age for several days to insure that polymerization was complete (2-6 days), the bathing buffer of the sol-gel is then changed as needed to suit the specific measurement.
Aquomet Hb T state sol-gel samples were prepared by encapsulating the deoxy Hb derivative, and, after the aging step, oxidized to the ferric (met) redox state using K 3 Fe(CN) 6 . The ferricyanide was flushed out of the sol-gel using several washings once conversion to met was complete. The bathing buffer was then replaced with PBS, pH 7.4. R state aquomet samples were prepared by first encapsulating the CO ligated Hb derivatives which, after the aging process, are then photolyzed in the presence of oxygen to remove and replace the CO, then purged with Ar to remove any residual oxygen, and then oxidized to met using the same technique described for the deoxy samples. Samples encapsulated as the O 2 ligated Hb were purged with Ar to remove any oxygen before treating with dithionite to form the R-state deoxy derivatives. In all cases optical absorption spectra were used to confirm the ligation and redox status of the encapsulated Hb species. Sol-gel encapsulated R and T state COHb derivatives of HbA and HbE were prepared as previously described in 0.05M Bis-Tris OAc, pH 7.0 as the bathing buffer (41, 63, 64) . The R state COHb samples were prepared by encapsulating the CO derivative directly. The T state samples were prepared by first encapsulating the deoxy derivative. After the sample is allowed to age in 0.05 M Bis-Tris OAc (pH 7.0), it is then flushed extensively with CO to form the ligated protein. Circular dichroism. Circular dichroism measurements on solution phase samples of deoxy and CO derivatives of HbA and HbE were performed on a Jasco J-815 CD spectrophotometer (Jasco Corp., Tokyo, Japan) in a 1 mm cuvette. CO recombination in sol-gel encapsulated Hb. CO recombination traces from encapsulated R and T state COHb derivatives were generated as previously described (63, 65, 66) . Photodissociation of the CO from the heme is triggered using a 7 ns pulse at 532 nm from a Nd:YAG laser. The recombination trace over several decades in time is generated from a change in absorption using the several milliwatt 442 nm output of a CW HeCd laser at as a probe of the evolving populations undergoing CO recombination. The recombination traces are displayed on a log-log plot of normalized absorbance (NA) versus time as previously described and discussed (67) (68) (69) (70) . Nitrite reductase activity pH 7.0: Deoxygenated hemoglobin samples were prepared in solution at pH 7.0 in 0.05 M Bis-Tris, 0.24 mM in heme as described in (41) with the exception that an excess of dithionite was added to a concentration of 1 mM. Nitrite was added in a slight excess of 1.1:1 to deoxy hemoglobin (Hb) to initiate the reaction. Under these conditions, the nitrite reductase reaction is modified in that the met (Hb + ) product generated from Hb + NO 2 -+ H +  Hb + + NO +OH¯ is reduced back to deoxy Hb by the excess dithionite. The deoxy Hb binds NO yielding the ferrous NO derivative of Hb (NOHb). As a result, the observed reaction consists overwhelmingly of the loss of deoxy Hb and the formation of NOHb as previously described (71) . Dithionite at this concentration does not reduce nitrite to NO (42, 71) .
The change in absorption was monitored on a Lambda 2 (Perkin Elmer, Norwalk, CT) as a function of time at 430 nm (Sôret band for deoxy HbA). The choice of the 430 nm band to follow the initial rate of decay of the starting deoxy species in solution is based on the relatively large extinction coefficient for deoxy Hb at that wavelength, -133,000 M -1 -cm -1 compared to (NOHb, ~8400, and met Hb, ~ 4000).
The higher optical density of sol-gel samples at 430 nm compared to the solution phase samples precluded the use of the Sôret to monitor the reaction in the sol-gels. For these samples, the Qband spectral region (480-650 nm) was scanned at regular 60 second intervals. The data were baseline corrected at each wavelength and the change in absorption plotted as a function of time. The initial linear portion was used to calculate initial rates.
For the sol-gels, the scanned Q-band spectra were also deconvoluted into populations of products using authentic standard basis sets and a program in Mathcad, V14.0 (Parametric Technology Corporation, Needham, MA). The resulting deoxy population was plotted as a function of time to assess the initial reductase rate. Nitrite reductase activity pH 7.4: The NR reaction was also monitored at pH 7.4 to enhance the R state contribution to the kinetics. Based on the known allosteric properties of metHb and partially liganded Hb, the various intermediates (found in the NR reaction) will switch from T to R more rapidly at the higher pH (72) . These R state partially liganded species are purported to be of physiological relevance (73). Deoxygenated hemoglobin samples were prepared in solution at pH 7.4 in 0.05 M Bis-Tris, 0.24 mM in heme with excess dithionite as described for the pH 7.0 measurements. The reaction was conducted in the absence and in the presence of the allosteric effector L35 (2-[4-(3,5-dichlorophenylureido) phenoxy] -2-methylpropionic acid) (44) at different nitrite:heme ratios. The L35, a gift from Drs. Iraj & Parvis Lalezari, was introduced into the reaction mixture in slight excess of the heme (1:1.1, heme:L35). The L35 was added to enhance the contribution of the T state population and thus allow for a clear distinction between the T and R state NR kinetics at pH 7.4. For this experiment, L35 has the advantage over IHP and DPG as a T state stabilizer in that it remains a potent effector at the higher pH (74) . The NR reaction in solution was followed at 430 nm as described above for the pH 7.0 samples.
The sol-gel T and R state samples were prepared in the same manner as at pH 7.0 with the exception that the bathing buffer was changed to pH 7.4 Reduction of aquomet Hb by L-Cys: Solution studies: Met Hb prepared from oxy HbA as described above, were purged with Ar as were all buffer solutions. The reactions were performed anerobically. The thiol stock solution (L-Cys) was prepared in the same buffer (PBS, pH 7.4) prior to addition to the protein. An aliquot of L-Cys (2 mM) was added to the met solution (0.38 mM heme) and the absorption was scanned at regular timed intervals using a 1 mm cuvette. The kinetic data was fit (Origin version 7.5) using the change in the unique 630 nm met Hb band as a function of time.
In all instances the starting aquomet Hb sample is reduced by the added thiol to form deoxy Hb. The conformation sensitive Q band (~ 555 nm for T and  558 nm for R) and near IR Band III (~758 nm for T and  760 nm for R) are used to confirm both the appearance of the ferrous five coordinate deoxy derivative and the quaternary structure status of the resulting deoxy population.
Reduction of aquomet Hb by L-Cys: Sol-gel studies:
Reduction by L-Cys of encapsulated samples was performed in PBS, pH 7.4 using 10 mM L-Cys prepared in the same Ar purged buffer. After oxidizing the T state or R state samples of HbE or HbA and flushing out K 3 Fe(CN) 6 as described above, the buffer was changed to PBS pH 7.4. An aliquot of L-Cys was added to initiate the reaction and the change in absorbance was monitored as a function of time. As noted above for the solution phase samples, the Q band at 555 nm and near IR band at 758 nm are used to monitor both the formation of the ferrous product and the quaternary status of the products.
RESULTS

STRUCTURAL STUDIES: High resolution crystal structures at or near physiological pH
Data collection and refinement statistics for the deoxy HbE structure are shown in Table 1 . The asymmetric unit of the low salt COHbE crystals contains one full heterotetramer. The overall structure of the tetramer is fairly similar to the previously reported low salt COHbA structure [Protein Data Bank entry (PDB) 1BBB] and CNHbE structure (PDB 1NQP) with RMS deviations of 0.36Å and 0.21Å between all tetramer Ca atoms (0.19Å and 0.13Å when β subunits are superimposed separately). Higher overall RMS deviation between tetramers as opposed to β subunits alone, indicate that COHbE and CNHbE are slightly closer in tertiary structure than COHbE and COHbA. (See Table 1 for data collection and refinement statistics.)
Structural superposition of the COHbE structures (under crystallizing conditions of high and low salt concentrations), and the deoxy HbE (crystallized under high salt concentration) structure with the respective HbA structures (derived from crystals grown under similar conditions) indicates that βLys26 is not involved in specific interactions with nearby residues, neither from the same subunit nor from the neighboring α-subunits (Figure 1a) . Nonetheless, the βLys26 side chain protrudes into the bulk solvent and interacts with solvent molecules. Since solvent structure varies in the three presented HbE structures and the crystal environment differs for different HbE subunits, the βLys26 side chain conformation as well as conformations of neighboring βHis117 and βGlu22 all show a high degree of variability. The orientation of the β 2 His116 [different from that of a cyanmet HbE structure (75) ] and the His β 2 117 side chains, as well as β 2 Lys22 are clearly altered in the COHbE structure (PDB 1YVQ) compared to COHbA (PDB 1BBB) (Figure 1b) . These findings help illuminate the reported in vitro HbE instability (see Discussion).
In contrast, the position of the βGlu26 side chain in HbA is stabilized through the hydrogen bond with the guanidinium group of βArg30, which in turn is positioned directly at the αβ chain interface and forms a hydrogen bond with αPhe117 carbonyl oxygen (Figure 1b) . The imidazole ring of βHis116 forms a hydrogen bond with the αPro114 carbonyl oxygen.
Evaluation of the extent of local and global structural consequences of βGlu26Lys mutation was achieved through superpositions between various human HbA and human HbE structures in the R and T states. The β1 subunits of each pair of structures were superimposed, and relative shifts of heme irons in each subunit of the tetramer were measured ( Table 2) . Apparently, the smallest shifts (0.2-0.5Å) occurred when the equivalent Hb states crystallized under similar conditions (high salt or low salt) were compared. These numbers suggest background RMS deviations between the equivalent structures are caused by experimental errors, slight differences in crystallization conditions, and crystal packing. The comparisons point to the known significant influence of salt concentration on Hb tertiary structure, especially in the CO (R-state) structures. Hence, structural superpositions between HbE and HbA under equivalent conditions do not reveal statistically significant differences [i.e., no significant conformational changes] at the allosteric transition sites, heme, and central cavity upon comparing these static structures.
Circular Dichroism: A solution phase comparison of HbE and HbA: Circular dichroism (CD) reports on the micro-environment of the heme as well as the secondary structure of the globin. The 285 nm CD region is sensitive to R/T specific differences at the α1β2 interface, specifically β37 Trp and α42Tyr, whereas the Soret, (410-450 nm and the 500-600 nm region) reports on changes in the heme environment (76). The R/T sensitive regions of the CD spectra are superimposable such that there is no discernable difference between HbE and HbA for both the deoxy and CO derivatives (data not shown). Very small differences in the heme absorption region (450 to 700 nm), seen in some comparisons for both derivatives, appear to be insignificant as they are within the range of the very small variation seen from sample to sample for the same protein.
The CD results are consistent with there being little if any difference between HbA and HbE with respect to tertiary structure within either the T or R quaternary states.
FUNCTIONAL STUDIES: Oxygen binding properties: A limited series of oxygen affinity measurements conducted at high and low salt concentrations in phosphate buffer, pH 7.4 revealed the same minor differences in the P 50 and Hill coefficient between HbA and HbE as previously reported. (19, 20) . Overall, the results are consistent with earlier reports that HbE oxygen binding is similar to HbA (19) .
CO recombination in sol-gels: Figure 2 shows the evolution of recombination traces for the T and R state forms of sol-gel encapsulated HbE and HbA. There is minimal variation as a function of hemoglobin species between the kinetic traces for CO recombination, following photolysis of CO for the sol-gel encapsulated COHb derivatives trapped as T state species. Both appear to display functional characteristics previously observed for T-state geminate recombination and solvent phase kinetics (63, 64, 77) . Once the CO binds to the sol-gel encapsulated T state deoxy Hb derivative, the protein population slowly (days) evolves from the nonequilibrium T state distribution of COHb conformations towards the R state equilibrium distribution of conformations associated with the COHb derivative (64, 69, 70) . This CO binding induced evolution from the T to R state distributions can be followed in the sol-gel where the greatly slowed conformational relaxation allows for facile monitoring of the evolution of the CO recombination trace from the T state pattern to that of the R state. Figure 2 shows that the rate at which the initially generated nonequilibrium T state population of COHb converts to the equilibrium R state COHb population is very similar for HbE and HbA. This observation indicates similar relative T/R state conformerstability for the two hemoglobins. (Stability as used here refers to stabilization of the allosteric T and R structures, and not to the intrinsic integrity of the tetramer.) The similar rate of evolution is consistent with the observation that allosteric parameters for HbE and HbA are very similar, consistent with that seen in the comparison of the crystal structures. We have observed that the CO binding induced T to R transition in the sol-gel under these conditions can be greatly accelerated or slowed depending on the relative stabilities of the T and R structures in a wide range of chemically and mutagenically modified hemoglobins (unpublished results). As a consequence, it can be concluded that the similar rates of conformational evolution seen for HbA and HbE are a good indication that the relative stability of the T and R states of these two Hbs are comparable.
Sol-gel samples of HbA and HbE encapsulated after saturation with CO served as functional six coordinate ferrous R state end points for both proteins (Figure 2) . In this case, there were minor R state differences both in geminate yield and in solvent phase recombination, with HbE manifesting a slightly lower geminate yield and slower solvent phase recombination than HbA. These differences are well within the range of R state variability seen in the geminate and solvent phase recombination (77) . Overall, the CO recombination results are consistent with similar reactivity and allosteric stability for the ferrous deoxy derivatives of HbA and HbE with minor differences noted for the R state HbE.
Nitrite reductase (NR) activity in solution at pH 7.0: Reactions of purified deoxy HbE at neutral pH in the presence of equivalent nitrite (~1:1 nitrite: heme) and an excess of dithionite were compared to HbA under near identical conditions. The reaction was monitored using two different approaches. In one case, the initial rates were generated by sitting at the 430 nm absorption maximum for the deoxy Hb Sôret Band and following the decrease in absorption as a function of time following the addition of nitrite. This method uses the absorption spectrometer in a time drive mode that can record changes in a single wavelength in 2 sec intervals. The advantage of this approach is that numerous data points are accumulated over the experimental time course and the end point is easily determined. Additionally, the reaction is monitored by repetitively scanning of either the Sôret Band region or the visible and near IR region of the absorption spectrum subsequent to the addition of the nitrite. The single wavelength monitoring was chosen for generating the actual initial rates because of the higher temporal resolution associated with that method. The successively scanned spectra both allow for verification of Hb species present during the course of the reaction and provide a rough check on the rates obtained by sitting at the Sôret band. Figure 3 shows decay of the deoxy population using the single wavelength monitoring technique, whereas the inset in Figure  3 shows a representative sequence of Sôret band traces showing the decay of the deoxy peak at 430 nm and the build-up of the NOHb peak at 418 nm.
It was found (using the absorption change in the Sôret band) that the initial rate of reaction was significantly slower (~2.5-fold) for deoxy HbE, Table 3 ). It is important to emphasize that these reactions were conducted in the presence of an excess of sodium dithionite (1 mM). The added dithionite simplifies the reaction and analysis by converting any generated met Hb back to the ferrous deoxy derivative. The scanned absorption spectra show that under these conditions with added dithionite, the initial deoxy population is essentially fully converted to ferrous NOHb indicating that (a) NO is being generated and (b) the met population is being reduced as it forms as previously reported (71) . It has been shown that added dithionite at concentrations below 10 mM (as in this case) does not affect the measured initial rates for the nitrite reductase reaction (42) . For the reactions presented here, the dithionite levels are well below this limit.
Nitrite reductase activity in sol-gels at pH 7.0. The sol-gel protocol permits the preparation of samples that remain locked into the T-state structure throughout the reaction, whether in the deoxygenated or oxygenated liganded form. Encapsulated T-state deoxy HbE samples consistently exhibit a significantly slower initial NR rate than the corresponding encapsulated Tstate deoxy HbA samples (Figure 4, Table 3 ). The initial rates reported in the table are derived from the initial decay of the deoxy population generated from plots of the deconvoluted time dependent changes of Hb species contributing to the observed spectra using basis sets as described in the Experimental Procedures section. Similar rates were also obtained using the decay at specific wavelengths. A representative plot of the evolving populations is shown as an insert in Figure 4 .
The NR reactions at pH 7 for the sol-gel deoxy R-state structures for both HbE and HbA were too fast to measure under similar conditions. We estimate that the R state rates are at least a factor of ten faster. Even at a ten-fold lower concentration of nitrite, the rapidity of the initial decay of the deoxy R state species made it difficult to obtain sufficient data points at early times to produce accurate enough initial R state rates for a reliable HbA/HbE comparison. Nonetheless, the difference in the much slower initial T state rate between HbE and HbA is clearly statistically significant. This T state difference in the initial rate indicates that the HbE/HbA difference in the initial solution phase rate is due, at least in part, to protein specific differences in the T state reactivity.
Nitrite Reductase activity in solution at pH 7.4: Solution phase NR rates at pH 7.4 were measured in an attempt to better expose R-state contributions as per the rationale described in Experimental Procedures. The same concentration of deoxy Hb (0.22 mM in heme) was used as for the pH 7.0 measurements. Three different concentrations of nitrite were used 1:1 nitrite:heme, 2:1 nitrite:heme, 3:1 nitrite:heme, in the absence and in the presence of L35. L35 is used to create kinetic traces reflective of a sustained T state population, thus allowing for a clear T/R differentiation as explained below. Representative time courses for the NR reaction at pH 7.4 are shown in Figure 5 .
In the presence of L35, the NR trace remains almost flat and linear with essentially no change or break in the trace from time zero to 2000 sec. For samples having the highest concentration of nitrite, (data not shown), a break is observed towards the very end of the reaction. The trace for samples, without the addition of L35, start out looking very similar to the L35-containing samples. However, after a relatively short (nitriteconcentration dependent) initial slow phase, there occurs a clear break that is followed by a much more rapid NR process.
The deoxy heme-derived low OD Band III (~ 760 nm) in the near IR region of the absorption spectrum is conformation sensitive (78) (79) (80) . The Band III peak position is ~ 758 nm for the deoxy T state, ~762 nm for the quasi-stable/relaxed deoxy R state and ~ 765 nm for the deoxy R state that retains the tertiary structure of the fully liganded R structure. All of the solution phase deoxy samples start out at ~ 758 nm, consistent with a T state designation. As the deoxy population decays during the NR reaction, the intensity of Band III decreases. For the L35 containing samples, the peak position of Band III does not noticeably shift as the intensity decreases during the time course of the NR reaction (data not shown) In contrast, the Band III spectra generated from the L35-free samples at time points just before, during and just after the break in the trace (denoted by arrows in Figure 5 ) show both a progressive decrease in Band III due to the loss of deoxy heme and a progressive broadening of the band with a clear red shift from the initial T state peak position at ~ 758 nm towards longer (redder) wavelengths (Figure 6 ). This red shift is consistent with the appearance of a population of R state deoxy hemes (78) (79) (80) at the time point where the kinetics begin to accelerate.
The kinetic traces for the samples with and without the L35 and the time dependent red shifting of Band III are consistent with assigning the fast NR phase to the emerging R state population that starts to appear at the point of the break. The rates for the fast NR phase obtained using the three different nitrite:heme ratios are presented in Table 4 . These rates are typically on the order of ten-fold faster than for the slower T state NR process obtained using the same nitrite ratios in the presence of L35. It is important to note that at each concentration of nitrite, both the fast and the slow rates for HbE are lower by a factor of two or more relative to HbA. This same pattern is observed for the slow phase at pH 7.0.
Sol-gel measurements of the R state deoxy gel samples at pH 7.4 are also consistent with slower rates for HbE (Table 4 , and representative spectra shown in Figure 7) . The peak positions for the Q band and Band III for the initial deoxy samples were ~ 559 nm and 766 nm, respectively for both R state deoxy samples. In contrast, the corresponding peak positions for samples encapsulated as the T state deoxy derivative are consistently 555 nm and ~ 756-758 nm). The 559 nm and 766 nm values are consistent with samples that are fully R state, with the tertiary structure of the initial species in the fully liganded R state. The sol-gel results support the claim, based on the solution phase study, that the R state NR rate is slower for HbE. Thus, it appears that, for both the T and R state forms of deoxy hemoglobin, the NR rates are slower for HbE compared to HbA.
Reduction rates of met Hb by L-Cys in the solution phase and in the sol-gel:
The redox potential has been invoked as a major determinant of Hb nitrite reductase activity (42, 81) . Relative to the R state, T-state stabilized hemoglobins are characterized by a higher redox potential (E 1/2 ) (40) which allegedly contributes to the lower R state rate for the NR reaction (40) . In lieu of traditional redox potential measurements that require large amounts of material and are conducted under conditions of questionable physiological relevance, we chose to use the redox sensitive rate of L-Cys induced reduction of aquomet Hb (45, 46) as a relative indicator of reduction potential (i.e., propensity to reduce). This approach also allows for redox comparisons of sol-gel encapsulated samples, which for obvious reasons, cannot be performed in standard redox potential measurements requiring a solution phase.
In solution, the rate of L-Cys induced formation of deoxy Hb from met Hb is faster for HbE compared to HbA (2.3 x 10 -3 + 0.4 sec vis a vis 2.1 x 10 -4 + 0.01 sec) (Figure 8 , Table 5 ). A possible origin for the difference in the rates of the thiol induced reduction is a difference in the R/T equilibrium between the two Hbs. If there is a substantial protein specific difference in the amount of R and T met Hb species in solution, the difference in redox property of the R and T state could account for the observed protein specific difference in reduction rates. Alternatively, there could be protein specific differences in the redox properties of the T and R states that could account for the observed solution phase results as well. Sol-gel encapsulation was used to trap the T and R state populations of met Hb under the same pH conditions thereby allowing for a direct relative comparison of the rates of reduction for the T and R state derivatives of both proteins.
Both T and R state sol-gel samples were oxidized to metHb in PBS, pH 7.4 buffer just prior to reaction with L-Cys as described in Experimental Procedures. Reduction of the T state met samples with L-Cys followed biphasic kinetics for both HbE and HbA, with HbE being slightly faster in both rates. Reduction of the R state met samples also manifested differences again with HbE faster than HbA. Sol-gel samples of HbE encapsulated initially as aquomet were also reduced more rapidly than the correspondingly encapsulated aquomet HbA samples (Figure 9, Table 5 ).
It is important to note that under the conditions employed and during the time-frame of these experimental measurements, relative structural instability is not indicated for aquomet HbE compared to aquomet HbA. In addition, a comparison of the time course for autooxidation of oxygenated forms of HbE and HbA reveals comparable autoxidation rates based on met Hb formation occurring over time-frames that exceed those of the reduction and reductase measurements (data not shown).
DISCUSSION
The findings presented demonstrate the first reported in vitro functional differences for HbE relative to HbA. The data implies that the functional difference arises from a difference in redox properties between the two hemoglobins. An explanation for the observed changes in nitrite reductase activity and L-Cys mediated reduction based on perturbed steric effects within the R and T state is unlikely, given the similarity between HbA and HbE with respect to geminate and solvent phase recombination profiles and the similarity between HbE and HbA high resolution crystal structures. In brief, the presented results appear most consistent with an explanation of the decreased nitrite reductase reactivity of HbE arising from an increase in the HbE redox potential relative to HbA.
Our crystallographic studies show that the hydrogen bonding changes at the site of mutation do not have a significant impact on either the allosterically important 12 interface or the local tertiary structure at the site of the heme. These structural findings are further supported by the lack of significant differences in the CD spectra between HbA and HbE. Ligand binding properties and allosteric parameters all indicate very minor differences in CO or O 2 reactivity between HbE and HbA. Based on the structural comparisons and the CO recombination measurements, it is not surprising that the oxygen affinity is not significantly affected by the mutation according to earlier reports (19) (20) and confirmed by our results.
Structural Impact of the β26 mutation: The structural findings do reflect upon earlier reported in vitro instability of this mutant (21) (22) (23) (24) . As shown in Figure 1 , the βLys26 substitution that results in a loss of H-bonds with a concomitant reorientation of the near neighbor βHis116 and the His β117 side chains and that of βLys22 may also account for the established in vitro integral instability of the HbE tetramer. Specifically, the in vitro instability of HbE may be attributed to the loss of the H-bond between the βGlu26 side chain with the guanidinium group of βArg30, and the subsequent H-bond loss of the latter with the αPhe117 carbonyl oxygen (positioned directly at the αβ chain interface); and secondly, to the electrostatic changes that originate from βArg30, βHis116, βHis117 and βHis122. Moreover, the charge repulsion in the microenvironment of β26 and the changes in the orientation of βHis116 and βHis117 are indicated as a major key to HbE instability and propensity for oxidation.
Evidence that βHis116 plays a critical role in stabilizing α1β1 interactions and inhibiting Hb oxidation, was presented by (82), using recombinant engineered Hb with β116 amino acid substitutions.
This resulted in increased autooxidation rates and decreased subunit association, all of which are characteristic of HbE. βHis116 near neighbor mutations result in clinical consequences: Hb Roma (βAla115Val) was identified in a heterozygous patient with mild erythrocytic hypochromia and microcytosis (83) . Compared to HbA, the hemolysate [75%HbA (with minor hemoglobins) and 25%Hb Roma, in the presence and absence of 2,3-biphosophoglycerate, exhibited increased oxygen affinity and mild destabilization.
Overall, the conformational changes observed at βHis116 and βHis117, communicated by the βLys26 substitution with the ensuing electrostatic change, may be the major attribute or at least a significant contributor that confers heightened in vitro instability of HbE. This is in contrast to a cyanmet HbE structure derived at high pH (75) wherein the authors attributed HbE thermal instability to the specific water structure observed in their cyanmet HbE structure derived at high pH. However, since water structure changes dramatically with crystallization conditions [as shown herein by our structures and in comparisons of published hemoglobin structures], their conclusion becomes unconvincing as the source of HbE instability.
Functional Impact of the β26 mutation. In the last decade, new hemoglobin functionalities have been proposed. For example, Hb has been implicated in the mechanism for hypoxic vasodilation (31, 35, 84) . Although there is still considerable controversy as to the nature of the Hb based mechanism, there is ample evidence that Hb can act as an allosterically controlled source of deliverable NO (84) (85) (86) (87) . One such proposed mechanism is based on deoxy hemoglobin functioning as a nitrite reductase converting nitrite to NO (37, 38, 88) . It is clear that the generation of bioactive NO under physiological conditions is not likely to be accounted for by just the nitrite reductase reaction. Other reactions and mechanisms are still under investigation (30, 36, (89) (90) (91) .
Nonetheless, there are clear indications of the role of this reaction as seen in studies that show that the efficacy of potential Hb based blood substitutes (HBOCs) are correlated with nitrite reductase activity (92) (93) (94) .
The nitrite reductase rate is clearly slower for deoxy HbE than for deoxy HbA. An obvious question is: through what mechanism does the HbE mutation create this change in reactivity? The presented results implicate a change in the intrinsic nitrite reductase activity of both T and R state forms of HbE. The decreased NR rates for deoxy hemes in both the T and R states of HbE relative to HbA, without evidence of a measurable change in the allosteric properties of HbE, point to a mechanism that directly affects the hemes in both quaternary states. This observation, along with the finding that there is an absence of significant differences in the X-ray structure, CO recombination kinetics and oxygen binding properties, indicates that it is neither the R/T equilibrium nor the ligand binding properties that are the basis for the decrease in NR activity for HbE T and R states. Instead, the HbE/HbA differences in the redox properties, suggest that the most likely mechanism for this alteration in the NR activity is a general increase in the redox potential for HbE that impacts the redox activity of both quaternary states.
In brief, the key impact of the HbE mutation upon function is manifested in the altered nitrite reductase activity observed in vitro. This finding has implications for pathophysiology and provides the basis for the proposal of a mechanism that may explain the contribution of HbE to pathophysiological consequences observed in HbE/β-thalassemia.
Implications for pathophysiology. HbE/β-thalassemia patients manifest endothelial dysfunction (95) . Endothelial dysfunction is associated with reduced production of NO through the eNOS pathway and increased production of ROS. Although still a subject of controversy, NO at the right concentration is likely to play a role in not only maintaining vascular tone but also scavenging ROS. It has been proposed that lowered levels of NO in the RBC can affect the stability of the RBC, and thus increase the rate of hemolysis which can be a major source of inflammation (96, 97) .
Impaired NO bioavailablity is reported to be linked to endothelial dysfunction and vascular pathology in hemoglobinopathies such as, sickle cell disease and thalassemia (98) (99) (100) (101) . Kato and Taylor (98) summarize NO-regulated pathways in vascular homeostasis that includes vasoconstriction, platelet-platelet interaction and attachment, release of procoagulant factors and growth factors. Animal models of sickle cell disease lend support to NO status as a contributing factor in these pathologies [e.g., (102, 103) ]. Although, the exact role of NO in sickle cell disease and thalassemia remains controversial (104) , the in vitro findings of a reduced nitrite reductase activity for HbE merits further consideration as a contributing factor to the pathophysiology, especially that of HbE/β-thalassemia.
Two HbE properties are plausible contributors to the clinical setting: i) the observed nitrite reductase properties of HbE are consistent with a reduced capacity to generate bioactive NO in a RBC, and ii) HbE has an enhanced affinity for RBC membrane [(HbE>HbC>HbS>HbA)] (105) (106) (107) . Based on these two properties, we propose the following mechanism for how HbE exacerbates β E -thalassemia. The RBC's in HbE/β-thalassemia patients are subject to stresses that contribute to RBC instability. Excess α-chains, arising from heterozygous thalassemia, produce heme, hemichromes, labile iron that yields ROS that bind to the lipid bilayer and Band 3. This situation would further compromise the RBC membrane that is already corrupted with the high binding affinity of HbE. The increased presence of reactive species may heighten HbE instability (in the cytosol and bound to the membrane) that in turn would further elevate free globin chains and levels of heme, hemichromes, labile Fe to override the intrinsic RBC protective redox enzymes, and give rise to a stressed RBC leading to further membrane abnormalities and hemolysis. Membrane dysfunction, including Band 3 (the anion transporter) would further interfere with the normal NO RBC physiology and "RBC NO metabolin" as proposed in (35) .
This backdrop of a stressed RBC coupled with the absence or reduction of the alleged protective attributes of NO should lead to a chronic enhanced RBC hemolysis and negative vascular consequences. An implication of this proposed NO associated mechanism is that therapeutic designs to elevate levels of bioactive NO, for example, by the use of GSNO, might off-set some of the clinical consequences of HbE/β-thalassemia.
The previously established enhanced binding of HbE to the RBC membrane may have additional consequences to further explain the HbE/β-thalassemia clinical picture. It has been proposed that Hb-containing RBC membrane fragments (i.e., microparticles) are taken up by macrophages which results in increased levels of inflammatory factors, such as cytokines (96, 97) . Enhanced Hb binding to RBC membrane fragments, yielded upon hemolysis, could result in a more potent trigger of inflammation and increased levels of potentially toxic nontransferrin carried iron. Inflammation and nonheme iron overload are clinical features of HbE/β-thalassemia (108, 109) . Thus, the novel finding of HbE as an altered nitrite reductase, coupled with the known enhanced binding of HbE to the RBC membrane in consideration of the aforementioned caveats, provides a new model to explain the severe pathophysiological consequences of HbE/β-thalassemia.
RBC and transgenic animal experiments are being designed to test the validity of this model.
In summary, the in vitro findings are most consistent with a decreased ability of HbE to generate NO from nitrite as a result of an increased HbE redox potential arising from small local tertiary structure changes in the heme environment engendered by the βLys26 substitution. Overall, this in vitro study reveals structural and functional properties of HbE with implications that provide a framework for a new paradigm of molecular and cellular mechanisms that may contribute to HbE associated pathophysiology. 
